Amneal Pharmaceuticals (AMRX) Surpasses Q3 Earnings and Revenue Estimates

Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of$ 0.13 per share. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 23.08%. A quarter ago, it was expected that this pharmaceutical company would post earnings of$ 0.14 per share when it actually produced earnings of $0.16, delivering a surprise of 14.29%. Over the last fou ...